In the US, Phendimetrazine (phendimetrazine systemic) is a member of the following drug classes: anorexiants, CNS stimulants and is used to treat Obesity.
US matches:
- Phendimetrazine
- Phendimetrazine Sustained-Release Capsules
- Phendimetrazine Tartrate
- Phendimetrazine Tablets
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0000634-03-7
Chemical Formula
C12-H17-N-O
Molecular Weight
191
Therapeutic Categories
Central stimulant
Anorexic agent
Chemical Name
Morpholine, 3,4-dimethyl-2-phenyl-, (2S-trans)-
Foreign Names
- Phendimetrazinum (Latin)
- Phendimetrazin (German)
- Phendimétrazine (French)
- Fendimetrazina (Spanish)
Generic Names
- Fendimetrazina (OS: DCIT)
- Phendimetrazine (OS: BAN)
- Phendimétrazine (OS: DCF)
- McN-R 747-11 (IS)
- Phenimethoxazine (IS)
- Sedafamen (IS)
- Phendimetrazine Tartrate (PH: USP 32)
Brand Names
- Adipost
Jones, United States
- Bontril
Valeant, United States
- Melfiat
Numark, United States
- Obex-LA
Adcock Ingram Pharmaceuticals, South Africa
- Phendimetrazine Tartate
Actavis, United States; Amide, United States; Hyrex, United States; Mikart, United States; Sandoz, United States
- X-Trozine
Shire, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and
International Nonproprietary Names.